The safety profile of home infusion of intravenous immunoglobulin in patients with neuroimmunologic disorders

Journal of Clinical Neuromuscular Disease
Nizar SouayahMohsin Jafri

Abstract

To assess the overall safety of high-dose intravenous immunoglobulin (IG) products used to treat patients with neuroimmunological disorders in a supervised home-based setting. The incidence of adverse reactions was assessed in a retrospective chart review of 420 patients who consecutively received 4076, home-based, individual, intravenous immunoglobulin (IVIG) infusions between January 2009 and December 2009. A total of 90 patients (21.4%) developed adverse reactions related to IVIG administration (2.6% per individual infusion). A total of 95.5% of adverse reactions were mild, and no serious side effects were observed. The incidence of adverse reactions was significantly lower in the subgroup of patients with neuroimmunological disorders who received premedication (18.2% compared with 29.3%, P = 0.02). There was no significant statistical difference in the incidence of side effects among the different brands of IVIG used in this study. The combination of premedication and well-defined clinical, IVIG infusion policies may reduce the incidence of high-dose IVIG adverse reactions administered in a home-based setting in patients with neuroimmunological disorders.

References

Oct 6, 1990·Lancet·D R McCluskey, N A Boyd
Jun 20, 1987·Lancet·D Chan-LamW S Douglas
Oct 31, 1987·British Medical Journal·C Barucha, J C McMillan
Jan 1, 1987·Journal of Clinical Immunology·J BjörkanderL A Hanson
Mar 1, 1995·Journal of Clinical Immunology·V M BrennanP Powell
Feb 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·T G CantúP J Scheel
Oct 1, 1993·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S A Misbah, H M Chapel
Feb 1, 1993·Archives of Neurology·E TanJ R Mendell
Mar 1, 1996·Muscle & Nerve·T E BertoriniJ H Jaster
Sep 1, 1996·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S Hansen-SchmidtF Keller
Jan 1, 1996·American Journal of Nephrology·N AhsanE C Manning
Oct 23, 1997·Clinical Neuropharmacology·M StangelR Gold
Dec 31, 1997·Mayo Clinic Proceedings·S M Yockey, I Ahmed
Aug 31, 1999·The Annals of Pharmacotherapy·J A HaskinD U Blank
Sep 16, 1999·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·U E Nydegger, M Sturzenegger
Dec 11, 1999·Dermatology : International Journal for Clinical and Investigative Dermatology·A BarbaudM C Béné
Feb 7, 2002·Annals of the Rheumatic Diseases·E HachullaM Yilmaz
Feb 7, 2002·Annals of the Rheumatic Diseases·J C Gerster, D Hohl
May 29, 2002·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·E Nobile-Orazio, A Bersano
Oct 23, 2003·Transfusion Medicine Reviews·L Ross Pierce, Nisha Jain
Nov 5, 2003·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·M C Dalakas
Apr 10, 2004·Pharmacoepidemiology and Drug Safety·V GrasG Decocq
May 20, 2004·JAMA : the Journal of the American Medical Association·Marinos C Dalakas
Dec 21, 2004·Seminars in Arthritis and Rheumatism·Hedi OrbachYehuda Shoenfeld
Jun 23, 2005·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Daphna ParanRonen Ben-Ami
Aug 18, 2005·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Elyse MurphyJardiolyn Valino Patterson
Jan 5, 2006·Clinical Reviews in Allergy & Immunology·Hedi OrbachYehuda Shoenfeld
Mar 1, 2006·International Immunopharmacology·David J Hamrock
Apr 4, 2006·The Journal of Allergy and Clinical Immunology·Jordan S OrangeUNKNOWN Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology
Jun 29, 2006·The Pediatric Infectious Disease Journal·Jessica Cowden, Sarah K Parker

❮ Previous
Next ❯

Citations

Apr 23, 2013·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Hans D KatzbergVera Bril
Dec 23, 2014·Human Fertility : Journal of the British Fertility Society·Luciano G NardoNeelam Potdar
Sep 20, 2015·Autoimmunity Reviews·Patrick CherinJean-François Viallard
Mar 13, 2014·Journal of the Peripheral Nervous System : JPNS·Eduardo Nobile-Orazio
Jun 25, 2015·Neurodegenerative Disease Management·Yusuf A RajaballyHans D Katzberg
Jul 24, 2015·Current Opinion in Neurology·Eduardo Nobile-Orazio, Francesca Gallia
May 8, 2020·Upsala Journal of Medical Sciences·Luciano Nardo, Spyridon Chouliaras
May 26, 2018·Journal of Clinical Neuromuscular Disease·Nizar SouayahHoward W Sander
Jul 27, 2017·Nursing·Trevor J BarnumSheila Haas
Jun 29, 2018·Frontiers in Immunology·Yi GuoZheng Xiao
Dec 17, 2020·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Elaine LiuAnita Siu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.